Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
The Phase I trial is planned to evaluate safety, tolerability, pharmacokinetics and
preliminary efficacy of MBS8(1V270) in subjects with advanced solid tumours. The trial is
designed to provide data for further clinical development of MBS8(1V270)